Risk of venous thromboembolism in patients with COVID-19: A systematic review and meta-analysis.
COVID‐19
prevalence
pulmonary embolism
severe acute respiratory syndrome coronavirus 2
venous thromboembolism
Journal
Research and practice in thrombosis and haemostasis
ISSN: 2475-0379
Titre abrégé: Res Pract Thromb Haemost
Pays: United States
ID NLM: 101703775
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
received:
16
07
2020
revised:
03
09
2020
accepted:
21
09
2020
pubmed:
13
10
2020
medline:
13
10
2020
entrez:
12
10
2020
Statut:
epublish
Résumé
Venous thromboembolism (VTE) is frequently observed in patients with coronavirus disease 2019 (COVID-19). However, reported VTE rates differ substantially. We aimed at evaluating available data and estimating the prevalence of VTE in patients with COVID-19. We conducted a systematic literature search (MEDLINE, EMBASE, World Health Organization COVID-19 database) to identify studies reporting VTE rates in patients with COVID-19. Studies with suspected high risk of bias were excluded from quantitative synthesis. Pooled outcome rates were obtained within a random effects meta-analysis. Subgroup analyses were performed for different settings (intensive care unit [ICU] vs non-ICU hospitalization and screening vs no screening) and the association of d-dimer levels and VTE risk was explored. Eighty-six studies (33,970 patients) were identified and 66 (28,173 patients, mean age: 62.6 years, 60.1% men, 19.4% ICU patients) were included in quantitative analysis. The overall VTE prevalence estimate was 14.1% (95% confidence interval [CI], 11.6-16.9), 40.3% (95% CI, 27.0-54.3) with ultrasound screening and 9.5% (95% CI, 7.5-11.7) without screening. Subgroup analysis revealed high heterogeneity, with a VTE prevalence of 7.9% (95% CI, 5.1-11.2) in non-ICU and 22.7% (95% CI, 18.1-27.6) in ICU patients. Prevalence of pulmonary embolism (PE) in non-ICU and ICU patients was 3.5% (95% CI, 2.2-5.1) and 13.7% (95% CI, 10.0-17.9). Patients developing VTE had higher d-dimer levels (weighted mean difference, 3.26 µg/mL; 95% CI, 2.76-3.77) than non-VTE patients. VTE occurs in 22.7% of patients with COVID-19 in the ICU, but VTE risk is also increased in non-ICU hospitalized patients. Patients developing VTE had higher d-dimer levels. Studies evaluating thromboprophylaxis strategies in patients with COVID-19 are needed to improve prevention of VTE.
Sections du résumé
Background
UNASSIGNED
Venous thromboembolism (VTE) is frequently observed in patients with coronavirus disease 2019 (COVID-19). However, reported VTE rates differ substantially.
Objectives
UNASSIGNED
We aimed at evaluating available data and estimating the prevalence of VTE in patients with COVID-19.
Methods
UNASSIGNED
We conducted a systematic literature search (MEDLINE, EMBASE, World Health Organization COVID-19 database) to identify studies reporting VTE rates in patients with COVID-19. Studies with suspected high risk of bias were excluded from quantitative synthesis. Pooled outcome rates were obtained within a random effects meta-analysis. Subgroup analyses were performed for different settings (intensive care unit [ICU] vs non-ICU hospitalization and screening vs no screening) and the association of d-dimer levels and VTE risk was explored.
Results
UNASSIGNED
Eighty-six studies (33,970 patients) were identified and 66 (28,173 patients, mean age: 62.6 years, 60.1% men, 19.4% ICU patients) were included in quantitative analysis. The overall VTE prevalence estimate was 14.1% (95% confidence interval [CI], 11.6-16.9), 40.3% (95% CI, 27.0-54.3) with ultrasound screening and 9.5% (95% CI, 7.5-11.7) without screening. Subgroup analysis revealed high heterogeneity, with a VTE prevalence of 7.9% (95% CI, 5.1-11.2) in non-ICU and 22.7% (95% CI, 18.1-27.6) in ICU patients. Prevalence of pulmonary embolism (PE) in non-ICU and ICU patients was 3.5% (95% CI, 2.2-5.1) and 13.7% (95% CI, 10.0-17.9). Patients developing VTE had higher d-dimer levels (weighted mean difference, 3.26 µg/mL; 95% CI, 2.76-3.77) than non-VTE patients.
Conclusion
UNASSIGNED
VTE occurs in 22.7% of patients with COVID-19 in the ICU, but VTE risk is also increased in non-ICU hospitalized patients. Patients developing VTE had higher d-dimer levels. Studies evaluating thromboprophylaxis strategies in patients with COVID-19 are needed to improve prevention of VTE.
Identifiants
pubmed: 33043231
doi: 10.1002/rth2.12439
pii: S2475-0379(22)02097-0
pmc: PMC7537137
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1178-1191Informations de copyright
© 2020 The Authors. Research and Practice in Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis (ISTH).
Références
Lancet Rheumatol. 2020 Jul;2(7):e393-e400
pubmed: 32835245
Eur J Intern Med. 2020 Jun;76:43-49
pubmed: 32482597
Circulation. 2020 Jul 14;142(2):184-186
pubmed: 32330083
Thromb Haemost. 2020 Sep;120(9):1339-1342
pubmed: 32575136
Thromb Res. 2020 Oct;194:116-118
pubmed: 32788102
Blood. 2010 Dec 9;116(24):5377-82
pubmed: 20829374
J Crit Care. 2005 Dec;20(4):341-7
pubmed: 16310605
Crit Care. 2020 Jun 16;24(1):353
pubmed: 32546188
Thromb Res. 2020 Sep;193:166-169
pubmed: 32707275
Thromb Haemost. 2020 Jun;120(6):998-1000
pubmed: 32316063
Thromb Res. 2020 Jul;191:151
pubmed: 32386985
Ann Intern Med. 2009 Aug 18;151(4):264-9, W64
pubmed: 19622511
Int J Cardiol. 2020 Aug 15;313:129-131
pubmed: 32471650
Crit Care Med. 2020 Nov;48(11):e1087-e1090
pubmed: 32769623
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
Blood. 2020 Jul 2;136(1):144-147
pubmed: 32462179
Lancet Haematol. 2020 Aug;7(8):e575-e582
pubmed: 32619411
Thromb Res. 2020 Sep;193:98
pubmed: 32534328
Circulation. 2020 Jul 14;142(2):181-183
pubmed: 32412320
Thromb Res. 2020 Aug;192:113-115
pubmed: 32425261
Clin Exp Rheumatol. 2020 Jul-Aug;38(4):754-759
pubmed: 32723434
Lancet. 2020 May 2;395(10234):1417-1418
pubmed: 32325026
TH Open. 2020 Jun 08;4(2):e113-e115
pubmed: 32529170
Hamostaseologie. 2020 Aug;40(3):264-269
pubmed: 32498097
Ann Hematol. 2020 Oct;99(10):2323-2328
pubmed: 32808105
J Thromb Thrombolysis. 2021 Jan;51(1):40-46
pubmed: 32613385
BMJ. 2015 Jan 02;350:g7647
pubmed: 25555855
J Thromb Haemost. 2020 Jun;18(6):1421-1424
pubmed: 32271988
Eur Heart J. 2020 Jul 1;41(32):3058-3068
pubmed: 32656565
N Engl J Med. 2020 Jul 9;383(2):120-128
pubmed: 32437596
J Thromb Haemost. 2020 Jul;18(7):1743-1746
pubmed: 32320517
N Engl J Med. 2020 Sep 3;383(10):994
pubmed: 32649078
Clin Infect Dis. 2011 Jan 15;52(2):e14-7
pubmed: 21288835
Thromb Res. 2020 Jul;191:148-150
pubmed: 32381264
BMC Med Res Methodol. 2014 Dec 19;14:135
pubmed: 25524443
Crit Care. 2020 Jun 2;24(1):275
pubmed: 32487122
Lancet. 2020 May 16;395(10236):1569-1578
pubmed: 32423584
J Thromb Haemost. 2020 Apr;18(4):844-847
pubmed: 32073213
Thromb Res. 2020 Oct;194:216-219
pubmed: 33074107
BMJ. 2006 Feb 11;332(7537):325-9
pubmed: 16439370
Thromb Res. 2020 Sep;193:1-4
pubmed: 32485437
J Thromb Haemost. 2020 Sep;18(9):2349-2357
pubmed: 32692862
J Thromb Thrombolysis. 2021 Apr;51(3):637-641
pubmed: 32812199
Crit Care Med. 2015 Feb;43(2):401-10
pubmed: 25474533
N Engl J Med. 2020 Jun 11;382(24):2372-2374
pubmed: 32302078
J Thromb Haemost. 2020 Oct;18(10):2629-2635
pubmed: 32692874
JAMA. 2020 Aug 25;324(8):799-801
pubmed: 32702090
Intern Emerg Med. 2020 Aug;15(5):865-870
pubmed: 32592114
N Engl J Med. 1999 Sep 9;341(11):793-800
pubmed: 10477777
Lancet Rheumatol. 2020 Jul;2(7):e437-e445
pubmed: 32835247
Blood. 2020 Jun 4;135(23):2033-2040
pubmed: 32339221
Radiology. 2020 Sep;296(3):E186-E188
pubmed: 32324103
J Thromb Haemost. 2020 May;18(5):1023-1026
pubmed: 32338827
Circulation. 2020 Jul 14;142(2):114-128
pubmed: 32421381
J Am Coll Cardiol. 2020 Jul 28;76(4):480-482
pubmed: 32479784
Arch Public Health. 2014 Nov 10;72(1):39
pubmed: 25810908
Thromb Res. 2020 Nov;195:95-99
pubmed: 32682004
Lancet Rheumatol. 2020 Sep;2(9):e549-e556
pubmed: 32838307
Intensive Care Med. 2020 Jun;46(6):1089-1098
pubmed: 32367170
Thromb Res. 2020 Jul;191:76-77
pubmed: 32402996
Res Pract Thromb Haemost. 2020 Jun 30;4(5):842-847
pubmed: 32685893
Thromb Res. 2020 Jul;191:9-14
pubmed: 32353746
Chirurg. 2020 Jul;91(7):588-594
pubmed: 32504106
Thromb Res. 2020 Dec;196:222-226
pubmed: 32916564
J Clin Med. 2020 Jun 08;9(6):
pubmed: 32521707
Circ Res. 2020 Jul 17;127(3):400-401
pubmed: 32508261
JAMA Netw Open. 2020 May 1;3(5):e2010478
pubmed: 32469410
Chest. 2020 Nov;158(5):2130-2135
pubmed: 32710891
JAMA. 2003 Jul 16;290(3):374-80
pubmed: 12865379
Circulation. 2004 Aug 17;110(7):874-9
pubmed: 15289368
Thromb Haemost. 2020 Aug;120(8):1230-1232
pubmed: 32349132
Int J Evid Based Healthc. 2015 Sep;13(3):147-53
pubmed: 26317388
JAMA. 2000 Apr 19;283(15):2008-12
pubmed: 10789670
J Thromb Haemost. 2020 Aug;18(8):1995-2002
pubmed: 32369666
J Thromb Haemost. 2020 Sep;18(9):2358-2363
pubmed: 32633068
J Crit Care. 2020 Dec;60:111-115
pubmed: 32799179
Intensive Care Med. 2020 Jun;46(6):1121-1123
pubmed: 32322918
Eur Heart J. 2020 May 14;41(19):1821-1829
pubmed: 32383763
Chest. 2020 Sep;158(3):1143-1163
pubmed: 32502594
Am J Trop Med Hyg. 2020 Aug;103(2):844-846
pubmed: 32618261
J Am Coll Surg. 2020 Aug;231(2):193-203.e1
pubmed: 32422349
Clin Med (Lond). 2020 Jul;20(4):e76-e81
pubmed: 32423903
J Med Virol. 2020 Jun;92(6):577-583
pubmed: 32162702
Thromb Res. 2020 Jul;191:145-147
pubmed: 32291094
Arterioscler Thromb Vasc Biol. 2020 Oct;40(10):2539-2547
pubmed: 32840379
J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973
pubmed: 32311448
J Thromb Haemost. 2020 Aug;18(8):1859-1865
pubmed: 32459046
J Thromb Haemost. 2020 May;18(5):1094-1099
pubmed: 32220112
Arterioscler Thromb Vasc Biol. 2020 Sep;40(9):2332-2337
pubmed: 32628040
Crit Care Med. 2020 Sep;48(9):e783-e790
pubmed: 32459672
Br J Haematol. 2020 Aug;190(3):e134-e137
pubmed: 32484907
J Thromb Thrombolysis. 2021 Feb;51(2):286-292
pubmed: 32794132
J Ultrasound. 2021 Jun;24(2):165-173
pubmed: 32809207
J Thromb Haemost. 2020 Jul;18(7):1738-1742
pubmed: 32302438
Dan Med J. 2020 Aug 12;67(9):
pubmed: 32800073
Res Pract Thromb Haemost. 2020 Oct 13;4(7):1178-1191
pubmed: 33043231
J Thromb Thrombolysis. 2020 Oct;50(3):558-566
pubmed: 32617807
J Thromb Thrombolysis. 2020 Aug;50(2):302-304
pubmed: 32504449
PLoS Curr. 2013 Nov 12;5:
pubmed: 24270606
Crit Care Explor. 2020 Jun 25;2(7):e0166
pubmed: 32766562
Int J Lab Hematol. 2020 Jun;42 Suppl 1:19-20
pubmed: 32311843
J Thromb Thrombolysis. 2016 Jan;41(1):3-14
pubmed: 26780736
Blood. 2020 Jul 23;136(4):489-500
pubmed: 32492712
J Vasc Surg Venous Lymphat Disord. 2021 Jan;9(1):36-46
pubmed: 32593770